An internal document advised staff at the international drug giant GlaxoSmithKline (GSK) to withhold clinical trial findings in 1998 that indicated the antidepressant paroxetine (Paxil in North America and Seroxat in the UK) had no beneficial effect in treating adolescents. ![Figure][1]
No takes yet. Share an insight, caveat, or question.
Wayne Kondro (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: